FdaApplication

NDA 201739

Back to search

Identifiers

Properties

PropertyValue
applicant_nameKALEO INC
application_typeNDA
approval_date2012-08-10

Products (3)

ProductActive ingredientStrengthDosage form
AUVI-QEPINEPHRINEEQ 0.15MG/DELIVERYSOLUTION;INTRAMUSCULAR, SUBCUTANEOUS
AUVI-QEPINEPHRINEEQ 0.3MG/DELIVERYSOLUTION;INTRAMUSCULAR, SUBCUTANEOUS
AUVI-QEPINEPHRINEEQ 0.1MG/DELIVERYSOLUTION;INTRAMUSCULAR, SUBCUTANEOUS

3 products